Janssen's greenfield Biomedicines Manufacturing Facility in Cork, which represents an investment of over €500m, is the first major Biotech facility to be fully designed in Ireland.
The facility produces monoclonal antibody products for the detection and treatment of many human diseases and also produces material for clinical trials. The Plant, which has been built on 30 acres of a 100 acre site near Cork’s Ringaskiddy area, consists of four separate buildings: a manufacturing facility; administration and laboroatory building; warehouse; and central utilities plant. All buildings are linked together by a central spine corridor. Supporting site infrastructure includes a utility yard, waste water treatment plant, roads, car parking and significant landscape architecture.
The plant features three bioreactors with pre-culture facilities, product recovery systems, purification systems, media preparation/hold facilities, buffer preparation/hold facilities, cleaning/sterilization systems, clean utilities and waste neutralization. The development includes 7,200 sqm of clean rooms and 2,600 sqm of QC/QA and IPC Laboratories.
The facility was winner of the ISPE ‘Facility of the Year Award’ 2009 in the sustainability category.
Client: Centocor
Programme: 2006 - 2009
Project value: £400 million
Area: 25,000 sqm
Status: Completed